查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1733393

全球烟酰胺腺嘌呤二核苷酸（NAD）市场：市场规模（按类型、应用和地区）、未来预测

Global Nicotinamide Adenine Dinucleotide (NAD) Market Size By Type (Pharmaceutical Grade, Food Grade), By Application (Dietary Supplement, Pharmaceutical Industry), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

烟酰胺腺嘌呤二核苷酸（NAD）市场规模及预测

烟酰胺腺嘌呤二核苷酸 (NAD) 市场规模在 2024 年价值 4.94 亿美元，预计到 2032 年将达到 8.734 亿美元，在预测期内（2026-2032 年）的复合年增长率为 14%。

NAD 用于催化化学反应，不仅产生能量，而且建造和修復构成我们身体的分子。 「全球烟酰胺腺嘌呤二核苷酸 (NAD) 市场」报告对市场进行了全面评估。它对关键细分市场、趋势、市场驱动因素、限制因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

定义全球烟酰胺腺嘌呤二核苷酸（NAD）市场

烟酰胺腺嘌呤二核苷酸 (NAD+) 是一种关键的吡啶核苷酸，是涉及氧化磷酸化和 ATP 生成、DNA 修復、表观遗传调控的基因表现表现、细胞内钙讯号传导和免疫功能的几种关键细胞基材的必需辅酶和底物。顾名思义，它是由两种核苷酸组成的，即腺嘌呤和烟酰胺。它们透过磷酸基团连接在一起。一般来说，NAD以氧化型和还原型两种形式存在，分别缩写为NAD+和NADH。此外，NAD 也可作为抗衰老的重要辅助手段。

现代生物学研究中最知名的 NAD 补充剂之一是 NADH，它是一种粒线体激素，其功能是提高细胞活力（抗衰老）。此外，NAD+ 主要用于分解代谢途径，与糖解作用一起分解能量分子以产生 ATP。所有活细胞的细胞呼吸过程都利用辅酶烟酰胺腺嘌呤二核苷酸 (NAD)。烟酰胺腺嘌呤二核苷酸（NAD）透过接受和捐赠电子在能量代谢中发挥关键作用。此外，烟酰胺腺嘌呤二核苷酸 (NAD) 增强剂可透过靶向细胞来对抗老化。这种补充剂可以促进身体抗衰老。然而，大多数 NAD+ 补充剂都含有烟碱酰胺核糖 (NR) 或烟碱酰胺单核苷酸 (NMN)。

全球烟酰胺腺嘌呤二核苷酸（NAD）市场概况

NAD 用于催化化学反应，不仅可以产生能量，还可以建造和修復构成我们身体的分子，这对市场需求产生影响并积极推动其成长。此外，NAD 还具有许多益处，例如帮助维持细胞健康。此外，烟酰胺腺嘌呤二核苷酸 (NAD) 增强剂可透过靶向细胞来对抗老化。此外，它还能增强免疫系统并帮助修復 DNA。它还有助于增强耐力和促进新陈代谢。因此，上述优势将有助于创造对烟酰胺腺嘌呤二核苷酸（NAD）的需求，进而促进市场成长；此外，人口老化和不良的饮食习惯也将有助于扩大该产业的需求。

使用 NAD 可以让您在正确的时间睡觉和吃饭，帮助市场成长。此外，世界各地人们的可支配收入不断增加，生活方式也在改变。因此，垃圾食物消费量正在上升。因此，增加垃圾食物的摄取量会导致体内胆固醇水平失衡。预计这将刺激对药品的需求并推动烟酰胺腺嘌呤二核苷酸 (NAD) 市场的成长。此外，NAD 可以由色氨酸和烟碱酸产生。此外，利用烟碱酰胺（NAD 降解产物）作为基材的 NAD 生成的「补救途径」在哺乳动物细胞中也广泛存在且充满活力，并且似乎被一部分人类癌症专门利用。

因此，NAD有潜力用于治疗大多数癌症。因此，全球心血管疾病的数量不断增加，对烟酰胺腺嘌呤二核苷酸 (NAD) 产生了需求，从而推动了烟酰胺腺嘌呤二核苷酸 (NAD) 市场的成长。然而，一些研究发现，过量摄取NAD 会引起一些副作用，包括噁心皮疹、头痛、头晕、腹胀以及毛孔和皮肤问题，包括搔痒和出汗。因此，这些副作用可能会阻碍市场的成长。

目录

第一章全球烟酰胺腺嘌呤二核苷酸（NAD）市场简介

  • 市场概览
  • 分析范围
  • 先决条件

第二章执行摘要

第三章 已验证的市场研究分析方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

4. 全球烟酰胺腺嘌呤二核苷酸（NAD）市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

5. 全球烟酰胺腺嘌呤二核苷酸（NAD）市场类型

  • 概述
  • 医药级
  • 食品级
  • 其他的

6. 全球烟酰胺腺嘌呤二核苷酸（NAD）市场应用

  • 概述
  • 营养补充品
  • 製药业
  • 其他的

7. 全球烟酰胺腺嘌呤二核苷酸（NAD）市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

8. 全球烟酰胺腺嘌呤二核苷酸（NAD）市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第九章 公司简介

  • Bontac Bioengineering
  • Hubei Widely Chemical Technology
  • Allergan
  • Synergy Pharmaceuticals
  • Novo Nordisk A/S
  • Oramed
  • Biocon India
  • Diabetology
  • Catalent
  • EnzymeWorks

第十章：主要趋势

  • 产品发布/开发
  • 企业合併与收购（M&A）
  • 业务扩展
  • 伙伴关係与合作

第十一章 附录

  • 相关分析
简介目录
Product Code: 65555

Nicotinamide Adenine Dinucleotide (NAD) Market Size And Forecast

Nicotinamide Adenine Dinucleotide (NAD) Market size was valued at USD 494 Million in 2024 and is projected to reach USD 873.4 Million by 2032, growing at a CAGR of 14% during the forecast period 2026-2032.

NAD is used to catalyze chemical reactions that are required to both generate energy as well as build and repair the molecules that make up our bodies which affect the market demand and positively increase the growth. The Global Nicotinamide Adenine Dinucleotide (NAD) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Nicotinamide Adenine Dinucleotide (NAD) Market Definition

Nicotinamide adenine dinucleotide (NAD+) is a vital pyridine nucleotide that serves as an essential cofactor and substrate for some of the crucial cellular processes involved in oxidative phosphorylation and ATP production, DNA repair, epigenetically modulated gene expression, intracellular calcium signaling, and immunological functions. As its name implies, it consists of 2 nucleotides one with an adenine base and the other with a nicotinamide base. They are joined by their phosphate groups. Generally, there are two types of NAD first one is oxidized, and the other is reduced form, which is abbreviated as NAD+ and NADH respectively. In addition, NAD may be used as a vital adjunctive drug against aging.

One of the most famous NAD supplements in modern biological research is NADH, a mitochondrial hormone whose function is to increase the existence cycle of cells (anti-aging). Furthermore, NAD+ is mostly utilized in catabolic pathways, together with glycolysis, that smashes down energy molecules to produce ATP. The cellular breathing processes of all living cells make use of the coenzyme Nicotinamide adenine dinucleotide (NAD). Also, it performs a key function in energy metabolism with the aid of using accepting and donating electrons. Furthermore, Nicotinamide adenine dinucleotide (NAD) boosters fight aging by targeting cells. The supplement promotes anti-aging results in the body. However, most NAD+ supplements include nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN).

Global Nicotinamide Adenine Dinucleotide (NAD) Market Overview

NAD is used to catalyze chemical reactions which are required to both generate energy as well as build and repair the molecules that make up our bodies which have an effect on the marketplace demand and positively boom the growth. In addition, there are numerous advantages are associated with NAD such as it helps in maintaining cell health. In addition, Nicotinamide adenine dinucleotide (NAD) boosters fight aging by targeting cells. Furthermore, it helps in boosting the immune system and repairing DNA. Also, it helps in increasing strength and boosting the metabolism. Thus, the above-mentioned benefits will create a demand for Nicotinamide Adenine Dinucleotide (NAD), which in turn help in boosting the marketplace growth, Furthermore, an aging populace and a poor diet will also assist in growing the demand for the industry.

The use of NAD helps you sleep and eat at the right time which drives the marketplace growth. Moreover, the increase in disposable income of human beings throughout the globe has led to changes in lifestyle. This, in turn, has boosted the consumption of junk meals. Therefore, an increase in the consumption of junk meals has caused an imbalance of levels of cholesterol in the body. This is likely to enhance the demand for medicines, thereby driving the Nicotinamide Adenine Dinucleotide (NAD) marketplace growth. Moreover, NAD may be generated from tryptophan or nicotinic acid. In addition, the "salvage pathway" of NAD production, which makes use of nicotinamide, a by-product of NAD degradation, as a substrate, is also extensively energetic in mammalian cells and looks to be extraordinarily exploited by a subset of human cancers.

Thus, NAD may be used for most cancers treatment. Therefore, a growing number of cardiovascular diseases across the world will create a demand for the Nicotinamide Adenine Dinucleotide (NAD), thereby driving the Nicotinamide Adenine Dinucleotide (NAD) marketplace growth. However, in some studies, it has been observed that excessive consumption of NAD causes some side effects which include nausea rashes, headache, dizziness, bloating, and pores and skin problems which include itching and sweating. Thus, these side effects factors may hamper the marketplace growth.

Global Nicotinamide Adenine Dinucleotide (NAD) Market Segmentation Analysis

The Global Nicotinamide Adenine Dinucleotide (NAD) Market Is Segmented On The Basis Of Type, Application And Geography.

Nicotinamide Adenine Dinucleotide (NAD) Market, By Type

  • Pharmaceutical Grade
  • Food Grade
  • Others

Nicotinamide Adenine Dinucleotide (NAD) Market, By TypeBased on Type, The market is bifurcated into Pharmaceutical Grade, Food Grade, and Others. The Pharmaceutical Grade segment is presumed to become the fastest-growing segment over the forecast period. Supplements that are made in a way to ensure an extremely excessive standard of purity and maximum absorption are certified pharmaceutical grade. In addition, pharmaceutical-grade merchandise must exceed 99% purity and not include any fillers, binders, dyes, or different inactive elements that serve as a vehicle for active substances.

  • Furthermore, there are numerous benefits are associated with a pharmaceutical-grade along with BioAvailability and Purity. For instance, increased bioavailability is a major advantage of pharmaceutical-grade supplements, which can be often made with patented technology. In addition, as mentioned, pharmaceutical-grade supplements are required to undergo thorough testing to be at least 99% pure. Thus, the above-mentioned benefits are the key factor that helps in boosting the segment growth.

Nicotinamide Adenine Dinucleotide (NAD) Market, By Application

  • Dietary Supplement
  • Pharmaceutical Industry
  • Others

Based on Application, The market is bifurcated into Dietary Supplement, Pharmaceutical Industry, and Others. Dietary supplements are anticipated to have the largest marketplace share during the forecast period. Nicotinamide adenine dinucleotide (NAD+) is an alternative form of the B3 vitamin and is acquired through the synthesis in the body or as a dietary source and supplement. It is required for over 500 enzymatic reactions and performs key roles in the regulation of almost all important biological processes. Above all, it may permit us to lead healthier and longer lives. In addition, it increases HDL levels and is used in the treatment of pellagra. Thus, demand for vitamin dietary supplements is increasing, owing to the rise in fitness awareness amongst consumers. This is driving the worldwide Nicotinamide Adenine Dinucleotide (NAD) marketplace.

Nicotinamide Adenine Dinucleotide (NAD) Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Geography, The Global Nicotinamide Adenine Dinucleotide (NAD) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is taking up the largest share in the Nicotinamide Adenine Dinucleotide (NAD) Market and it is estimated that the region will continue dominating the market until the next couple of years. Growing awareness related to the health benefits among the consumer is the key factor that helps in boosting the market growth in the region. In addition, a growing number of cardiovascular diseases in the region will create a demand for the Nicotinamide Adenine Dinucleotide (NAD), thereby driving the Nicotinamide Adenine Dinucleotide (NAD) marketplace growth.

Key Players

The "Global Nicotinamide Adenine Dinucleotide (NAD) Market," study report will provide a valuable insight with an emphasis on the global market, including some of the major players such as Bontac Bioengineering, Hubei Widely Chemical Technology, Allergan, Synergy Pharmaceuticals, Novo Nordisk A/S, Oramed, Biocon India, Diabetology, Catalent, and EnzymeWorks.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In December 2021, Novo Nordisk announces the completion of the Dicerna Pharmaceuticals acquisition. At the completion of the merger, Dicerna became a wholly-owned subsidiary of Novo Nordisk. The common stock of Dicerna will no longer be listed or traded on the Nasdaq Global Select Market.
  • In December 2021, Biocon Ltd partners with Tabuk Pharmaceuticals to commercialize its specialty generic medicines in the Middle East. The partnership will pave the way for Biocon's expansion into the MENA region to include Saudi Arabia, UAE, Kuwait, Qatar, Oman, and Iraq, in addition to Jordan and Lebanon. This is another important milestone for Biocon, reflecting its commitment to providing patients around the globe with affordable medications, by establishing a strong global portfolio of products, either directly, or through strategic partnerships.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Pharmaceutical Grade
  • 5.3 Food Grade
  • 5.4 Others

6 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Dietary Supplement
  • 6.3 Pharmaceutical Industry
  • 6.4 Others

7 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East And Africa

8 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Bontac Bioengineering
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Hubei Widely Chemical Technology
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Allergan
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Synergy Pharmaceuticals
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Novo Nordisk A/S
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Oramed
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Biocon India
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Diabetology
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Catalent
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 EnzymeWorks
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research